EE200000694A - Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon - Google Patents

Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon

Info

Publication number
EE200000694A
EE200000694A EEP200000694A EEP200000694A EE200000694A EE 200000694 A EE200000694 A EE 200000694A EE P200000694 A EEP200000694 A EE P200000694A EE P200000694 A EEP200000694 A EE P200000694A EE 200000694 A EE200000694 A EE 200000694A
Authority
EE
Estonia
Prior art keywords
iterferon
ifn
beta
formulation
recombinant human
Prior art date
Application number
EEP200000694A
Other languages
English (en)
Inventor
Alam John
Rogge Mark
Goelz Susan
Original Assignee
Biogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc. filed Critical Biogen, Inc.
Publication of EE200000694A publication Critical patent/EE200000694A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200000694A 1998-05-29 1998-05-29 Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon EE200000694A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
EE200000694A true EE200000694A (et) 2002-06-17

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000694A EE200000694A (et) 1998-05-29 1998-05-29 Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon

Country Status (16)

Country Link
EP (1) EP1082132A1 (et)
JP (1) JP2002516874A (et)
KR (1) KR20010052454A (et)
CN (1) CN1299285A (et)
AU (1) AU8822598A (et)
BR (1) BR9815966A (et)
CA (1) CA2333063A1 (et)
EA (1) EA200001252A1 (et)
EE (1) EE200000694A (et)
HU (1) HUP0102241A2 (et)
IL (1) IL139933A0 (et)
IS (1) IS5732A (et)
NO (1) NO20006022L (et)
SK (1) SK17762000A3 (et)
TR (1) TR200003521T2 (et)
WO (1) WO1999062542A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
JP2004525874A (ja) * 2000-12-21 2004-08-26 リサスサイテック， インコーポレイテッド 安定したｔ３の組成物およびその使用方法
CN1325651C (zh) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 人重组乙型干扰素的高效表达及其应用
CN1535724B (zh) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途
CA3123813C (en) * 2007-12-04 2024-10-08 Remedy Pharmaceuticals, Inc. IMPROVED GLIBENCLAMIDE FORMULATIONS AND RELATED FREEZE-DRYING METHODS, AND FREEZE-DRY SATE PRODUCED THUS
WO2022056233A1 (en) * 2020-09-12 2022-03-17 Academia Sinica Re-folded human serum albumin and use thereof for anti-tumor

Also Published As

Publication number Publication date
EA200001252A1 (ru) 2001-06-25
CN1299285A (zh) 2001-06-13
NO20006022L (no) 2001-01-26
IS5732A (is) 2000-11-24
WO1999062542A1 (en) 1999-12-09
CA2333063A1 (en) 1999-12-09
KR20010052454A (ko) 2001-06-25
HUP0102241A2 (hu) 2001-10-28
AU8822598A (en) 1999-12-20
BR9815966A (pt) 2001-02-28
EP1082132A1 (en) 2001-03-14
JP2002516874A (ja) 2002-06-11
NO20006022D0 (no) 2000-11-28
TR200003521T2 (tr) 2001-07-23
IL139933A0 (en) 2002-02-10
SK17762000A3 (sk) 2001-07-10

Similar Documents

Publication Publication Date Title
FI20055562L (fi) Alfa-interferonin stabiilit vesiliuosformulaatit
FI972657L (fi) Proteiinien ja peptidien aerosoliformuloinnit
DE59505055D1 (de) Dermal applizierbare formulierungen von parasitiziden
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
IS2325B (is) Örgerðar samsetningar epleróns
NO20004540L (no) Sammensetninger av peptider, formuleringer og anvendelse derav
NO983364D0 (no) Konsensusproteiner
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
IS5191A (is) Örverueyðandi hindrun og meðferð gegn eyðniveirunni og öðrum smitsjúkdómum í mönnum
DE69826451D1 (de) Anästehischer knochenzement
EP1040117A4 (en) 110 HUMAN SECRETED PROTEINS
ID26999A (id) Komposisi perawatan kulit
CY2006006I1 (el) Πρωτεϊνικα σκευασματα
DE69719083D1 (de) Neuartige orale Zubereitungen von Calcitonin
DE69925820D1 (de) Zubereitungen zur stabilisierung von peg-interferon alpha konjugaten
DE69822559D1 (de) Siliconzusammensetzung
NO20000575D0 (no) Rekombinant ekspresjon av insulin C-peptid
EP1012262A4 (en) Human frezzled-like protein
DE69837507D1 (de) Humanes Hedgehog-Protein
DE69903553D1 (de) Verkapselung wasserlöslicher peptide
EP1144614A4 (en) HUMAN, ELIMINATED PROTEINS
EP1169332A4 (en) 49 HUMAN SECRETED PROTEINS
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
NO20006022D0 (no) Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering
DE69930733D1 (de) Herstellung von substituierten (amino)alkoxysilanen